静脈内ソリューションの世界市場2020-2026:クリスタロイド、コロイド、その他

QYResearchが発行した調査報告書(QYR20AP01174)
◆英語タイトル:Global Intravenous Solutions Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP01174
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、静脈内ソリューションの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、静脈内ソリューションのグローバル市場動向、メーカー別競争状況、種類別市場規模(クリスタロイド、コロイド、その他)、用途別市場規模(基本的IVソリューション、栄養輸液、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・静脈内ソリューションの種類別市場2015-2026:クリスタロイド、コロイド、その他
・静脈内ソリューションの用途別市場2015-2026:基本的IVソリューション、栄養輸液、その他
・静脈内ソリューションの北米市場分析
・静脈内ソリューションのアジア市場分析
・静脈内ソリューションの中南米市場分析
・静脈内ソリューションの中東・アフリカ市場分析
・関連企業情報:Baxter、Hospira、B. Braun Melsungen、Fresenius Kabi、Claris Lifesciences、Grifols、Vifor Pharma、JW Life Science
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.The North America average price of intravenous solutions is in the increasing trend, from 404 USD/K Units in 2011 to 417 USD/K Units in 2016.

The classification of intravenous solutions includes crystalloids, colloids, and other. The proportion of crystalloids in 2016 is about 78%, and the proportion keeps steady.

Intravenous solutions are widely used for basic IV solutions, nutrient infusion solution. The most proportion of intravenous solutions is basic IV solutions, and the consumption in 2016 is 2627 M units.

USA is the largest consumption place, with a consumption market share nearly 81% in 2016. Following USA, Canada is the second largest consumption place with the consumption market share of 10%. Mexico consumption market share is about 7%.

The market is relatively concentrated. Baxter, Hospira, B. Braun Melsungen, Fresenius Kabi.are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
In 2019, the global Intravenous Solutions market size was US$ 1783 million and is forecast to US$ 2037.2 million in 2026, growing at a CAGR of 1.9% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Intravenous Solutions.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Intravenous Solutions market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Intravenous Solutions market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Intravenous Solutions market. Readers of the report can become informed about current and future trends of the global Intravenous Solutions market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Intravenous Solutions markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Intravenous Solutions market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Intravenous Solutions market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Intravenous Solutions market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Intravenous Solutions market is segmented into
Crystalloids
Colloids
Others

Market Segment by Application, the Intravenous Solutions market is segmented into
Basic IV Solutions
Nutrient Infusion Solution
Others

This report includes the following manufacturers; we can also add the other companies as you want.
Baxter
Hospira
B. Braun Melsungen
Fresenius Kabi
Claris Lifesciences
Grifols
Vifor Pharma
JW Life Science

The study objectives are:
To analyze and research the global Intravenous Solutions status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Intravenous Solutions manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Intravenous Solutions are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Intravenous Solutions Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Intravenous Solutions Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Crystalloids
1.3.3 Colloids
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Intravenous Solutions Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Basic IV Solutions
1.4.3 Nutrient Infusion Solution
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Intravenous Solutions Revenue (2015-2026)
2.1.1 Global Intravenous Solutions Revenue (2015-2026)
2.1.2 Global Intravenous Solutions Sales (2015-2026)
2.2 Intravenous Solutions Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Intravenous Solutions Sales by Regions (2015-2020)
2.2.2 Global Intravenous Solutions Revenue by Regions (2015-2020)
2.3 Global Top Intravenous Solutions Regions (Countries) Ranking by Market Size
2.4 Intravenous Solutions Industry Trends
2.4.1 Intravenous Solutions Market Top Trends
2.4.2 Market Drivers
2.4.3 Intravenous Solutions Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Intravenous Solutions Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Intravenous Solutions Manufacturers by Sales (2015-2020)
3.1.1 Global Intravenous Solutions Sales by Manufacturers (2015-2020)
3.1.2 Global Intravenous Solutions Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Intravenous Solutions Sales in 2019
3.2 Global Top Manufacturers Intravenous Solutions by Revenue
3.2.1 Global Intravenous Solutions Revenue by Manufacturers (2015-2020)
3.2.2 Global Intravenous Solutions Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Intravenous Solutions Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Solutions as of 2019)
3.4 Global Intravenous Solutions Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Intravenous Solutions Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Intravenous Solutions Market
3.7 Key Manufacturers Intravenous Solutions Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Intravenous Solutions Historic Market Review by Type (2015-2020)
4.1.2 Global Intravenous Solutions Sales Market Share by Type (2015-2020)
4.1.3 Global Intravenous Solutions Revenue Market Share by Type (2015-2020)
4.1.4 Intravenous Solutions Price by Type (2015-2020)
4.1 Global Intravenous Solutions Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Intravenous Solutions Sales Forecast by Type (2021-2026)
4.2.3 Global Intravenous Solutions Revenue Forecast by Type (2021-2026)
4.2.4 Intravenous Solutions Price Forecast by Type (2021-2026)

5 Global Intravenous Solutions Market Size by Application
5.1 Global Intravenous Solutions Historic Market Review by Application (2015-2020)
5.1.2 Global Intravenous Solutions Sales Market Share by Application (2015-2020)
5.1.3 Global Intravenous Solutions Revenue Market Share by Application (2015-2020)
5.1.4 Intravenous Solutions Price by Application (2015-2020)
5.2 Global Intravenous Solutions Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Intravenous Solutions Sales Forecast by Application (2021-2026)
5.2.3 Global Intravenous Solutions Revenue Forecast by Application (2021-2026)
5.2.4 Intravenous Solutions Price Forecast by Application (2021-2026)

6 North America
6.1 North America Intravenous Solutions Breakdown Data by Company
6.2 North America Intravenous Solutions Breakdown Data by Type
6.3 North America Intravenous Solutions Breakdown Data by Application
6.4 North America Intravenous Solutions Breakdown Data by Countries
6.4.1 North America Intravenous Solutions Sales by Countries
6.4.2 North America Intravenous Solutions Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Intravenous Solutions Breakdown Data by Company
7.2 Europe Intravenous Solutions Breakdown Data by Type
7.3 Europe Intravenous Solutions Breakdown Data by Application
7.4 Europe Intravenous Solutions Breakdown Data by Countries
7.4.1 Europe Intravenous Solutions Sales by Countries
7.4.2 Europe Intravenous Solutions Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Intravenous Solutions Breakdown Data by Company
8.2 Asia Pacific Intravenous Solutions Breakdown Data by Type
8.3 Asia Pacific Intravenous Solutions Breakdown Data by Application
8.4 Asia Pacific Intravenous Solutions Breakdown Data by Regions
8.4.1 Asia Pacific Intravenous Solutions Sales by Regions
8.4.2 Asia Pacific Intravenous Solutions Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Intravenous Solutions Breakdown Data by Company
9.2 Latin America Intravenous Solutions Breakdown Data by Type
9.3 Latin America Intravenous Solutions Breakdown Data by Application
9.4 Latin America Intravenous Solutions Breakdown Data by Countries
9.4.1 Latin America Intravenous Solutions Sales by Countries
9.4.2 Latin America Intravenous Solutions Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Intravenous Solutions Breakdown Data by Type
10.2 Middle East and Africa Intravenous Solutions Breakdown Data by Application
10.3 Middle East and Africa Intravenous Solutions Breakdown Data by Countries
10.3.1 Middle East and Africa Intravenous Solutions Sales by Countries
10.3.2 Middle East and Africa Intravenous Solutions Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Baxter Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Baxter Intravenous Solutions Products and Services
11.1.5 Baxter SWOT Analysis
11.1.6 Baxter Recent Developments
11.2 Hospira
11.2.1 Hospira Corporation Information
11.2.2 Hospira Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Hospira Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Hospira Intravenous Solutions Products and Services
11.2.5 Hospira SWOT Analysis
11.2.6 Hospira Recent Developments
11.3 B. Braun Melsungen
11.3.1 B. Braun Melsungen Corporation Information
11.3.2 B. Braun Melsungen Business Overview and Total Revenue (2019 VS 2018)
11.3.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 B. Braun Melsungen Intravenous Solutions Products and Services
11.3.5 B. Braun Melsungen SWOT Analysis
11.3.6 B. Braun Melsungen Recent Developments
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Corporation Information
11.4.2 Fresenius Kabi Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Fresenius Kabi Intravenous Solutions Products and Services
11.4.5 Fresenius Kabi SWOT Analysis
11.4.6 Fresenius Kabi Recent Developments
11.5 Claris Lifesciences
11.5.1 Claris Lifesciences Corporation Information
11.5.2 Claris Lifesciences Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Claris Lifesciences Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Claris Lifesciences Intravenous Solutions Products and Services
11.5.5 Claris Lifesciences SWOT Analysis
11.5.6 Claris Lifesciences Recent Developments
11.6 Grifols
11.6.1 Grifols Corporation Information
11.6.2 Grifols Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Grifols Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Grifols Intravenous Solutions Products and Services
11.6.5 Grifols SWOT Analysis
11.6.6 Grifols Recent Developments
11.7 Vifor Pharma
11.7.1 Vifor Pharma Corporation Information
11.7.2 Vifor Pharma Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Vifor Pharma Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Vifor Pharma Intravenous Solutions Products and Services
11.7.5 Vifor Pharma SWOT Analysis
11.7.6 Vifor Pharma Recent Developments
11.8 JW Life Science
11.8.1 JW Life Science Corporation Information
11.8.2 JW Life Science Business Overview and Total Revenue (2019 VS 2018)
11.8.3 JW Life Science Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 JW Life Science Intravenous Solutions Products and Services
11.8.5 JW Life Science SWOT Analysis
11.8.6 JW Life Science Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Intravenous Solutions Sales Channels
12.2.2 Intravenous Solutions Distributors
12.3 Intravenous Solutions Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Intravenous Solutions Sales Forecast (2021-2026)
13.1.1 Global Intravenous Solutions Sales Forecast by Regions (2021-2026)
13.1.2 Global Intravenous Solutions Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Intravenous Solutions Sales Forecast (2021-2026)
13.2.2 North America Intravenous Solutions Revenue Forecast (2021-2026)
13.2.3 North America Intravenous Solutions Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Intravenous Solutions Sales Forecast (2021-2026)
13.3.2 Europe Intravenous Solutions Revenue Forecast (2021-2026)
13.3.3 Europe Intravenous Solutions Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Intravenous Solutions Sales Forecast (2021-2026)
13.4.2 Asia Pacific Intravenous Solutions Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Intravenous Solutions Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Intravenous Solutions Sales Forecast (2021-2026)
13.5.2 Latin America Intravenous Solutions Revenue Forecast (2021-2026)
13.5.3 Latin America Intravenous Solutions Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Intravenous Solutions Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Intravenous Solutions Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Intravenous Solutions Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Baxter、Hospira、B. Braun Melsungen、Fresenius Kabi、Claris Lifesciences、Grifols、Vifor Pharma、JW Life Science

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 静脈内ソリューションの世界市場2020-2026:クリスタロイド、コロイド、その他(Global Intravenous Solutions Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。